By Elaine Rigoli
Tampa, Fla., May 16 - Nanosphere, Inc. has closed $57 million in series D financing, led by Bain Capital, LLC. Other investors included Brookside Capital, Allen & Co. and founding investor Lurie Investments.
The company said it will use the proceeds to commercialize the Verigene system, a platform for user-friendly, cost-effective direct genomic testing that eliminates the need for polymerase chain reaction.
Nanosphere also said it will continue development and commercialization of its proprietary Biobarcode technology for ultra-sensitive detection of proteins and nucleic acids.
Based in Northbrook, Ill., Nanosphere is a privately held nanotechnology-based molecular diagnostics company.
| Issuer: | Nanosphere, Inc.
|
| Issue: | Series D financing
|
| Amount: | $57 million
|
| Investors: | Bain Capital LLC, Brookside Capital, Allen & Co. and Lurie Investments
|
| Announcement date: | May 16
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
